Please login to the form below

Not currently logged in
Email:
Password:

Contract research organisation PRA opens Singapore office

Continues its Asia-Pacific expansion with new centralised operations base

PRA has opened a new office in Singapore that will act as a centralised operations base for its activities in the region.

The US contract research organisation's new facility will provide monitoring, project management, safety reporting, feasibility and other services.

Helen Neal, PRA's director of clinical operations for Asia-Pacific, said: "Building our capability across the region with the centre in Singapore permits our sponsors to experience a wider range of services and expertise.

"This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

PRA has been steadily expanding its Asia-Pacific operations since 2000 and its operations in the region also include Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

The expansion mirrors investments from the pharma industry in new research operations. Last year Merck & Co pledged $1.5bn to expand its presence in China and Bayer said it expects Asia to account for €11bn of sales by 2015.

24th February 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics